Stay updated with breaking news from Lynne weedall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Barclays reiterated their overweight rating on shares of Dr. Martens (LON:DOCS – Get Rating) in a report released on Monday, Marketbeat reports. The firm currently has a GBX 175 ($2.18) price target on the stock. A number of other analysts also recently commented on DOCS. Numis Securities reissued an add rating and set a GBX […] ....
Barclays reissued their overweight rating on shares of Dr. Martens (LON:DOCS – Get Rating) in a research report released on Monday morning, MarketBeat Ratings reports. The brokerage currently has a GBX 175 ($2.18) price target on the stock. A number of other analysts have also recently weighed in on DOCS. Numis Securities reiterated an add […] ....
Dr. Martens plc (LON:DOCS – Get Rating) insider Lynne Weedall acquired 4,000 shares of the business’s stock in a transaction that occurred on Monday, June 5th. The stock was bought at an average cost of GBX 136 ($1.69) per share, for a total transaction of £5,440 ($6,762.80). Dr. Martens Price Performance LON:DOCS opened at GBX […] ....